当前位置:
X-MOL 学术
›
Hypertension
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
GSK2256294 Decreases sEH (Soluble Epoxide Hydrolase) Activity in Plasma, Muscle, and Adipose and Reduces F2-Isoprostanes but Does Not Alter Insulin Sensitivity in Humans
Hypertension ( IF 6.9 ) Pub Date : 2021-08-30 , DOI: 10.1161/hypertensionaha.121.17659 James M Luther 1 , Justina Ray 2 , Dawei Wei 1 , John R Koethe 3 , Latoya Hannah 3 , Anthony DeMatteo 1 , Robert Manning 1 , Andrew S Terker 4 , Dungeng Peng 1 , Hui Nian 5 , Chang Yu 5 , Mona Mashayekhi 6 , Jorge Gamboa 1 , Nancy J Brown 1, 7
中文翻译:
GSK2256294 降低血浆、肌肉和脂肪中的 sEH(可溶性环氧化物水解酶)活性并减少 F2-异前列腺素,但不会改变人类的胰岛素敏感性
更新日期:2021-09-09
Hypertension ( IF 6.9 ) Pub Date : 2021-08-30 , DOI: 10.1161/hypertensionaha.121.17659 James M Luther 1 , Justina Ray 2 , Dawei Wei 1 , John R Koethe 3 , Latoya Hannah 3 , Anthony DeMatteo 1 , Robert Manning 1 , Andrew S Terker 4 , Dungeng Peng 1 , Hui Nian 5 , Chang Yu 5 , Mona Mashayekhi 6 , Jorge Gamboa 1 , Nancy J Brown 1, 7
Affiliation
中文翻译:
GSK2256294 降低血浆、肌肉和脂肪中的 sEH(可溶性环氧化物水解酶)活性并减少 F2-异前列腺素,但不会改变人类的胰岛素敏感性